February 23, 2025 - 12:57
A recent survey revealed that Korea's semiconductor technology has fallen behind China's across all critical sectors as of last year. This marks a significant change from earlier evaluations, which suggested that Korea maintained a competitive edge in semiconductor advancements. The survey highlights a growing concern among industry experts and stakeholders regarding Korea's position in the global semiconductor market.
The findings indicate that China has made substantial strides in semiconductor research and development, manufacturing capabilities, and technological innovation. This shift could have far-reaching implications for Korea's economy, particularly as the semiconductor industry is a vital component of its manufacturing sector.
Experts suggest that Korea must invest more in research and development, foster collaboration between academia and industry, and enhance its talent pool to regain its competitive advantage. The survey serves as a wake-up call for policymakers and business leaders to reassess strategies and prioritize initiatives that can bolster Korea's semiconductor technology in the face of fierce competition from China.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...